HOME >> BIOLOGY >> NEWS
ESMO Summer Educational Conference, ESEC

You are invited to report on one of Europe's most important educational cancer conferences

There are few fields in clinical medicine that are expanding as rapidly as oncology. Don't miss your chance to report on the latest updates in treatment for cancer patients.

This 'one-step educational experience' will focus on conventional medical oncology such as gynecological and colorectal tumors, as well as emerging fields like psycho-oncology and quality-of-life. ESEC will confront difficult situations and areas of treatment that require special attention. It will address the question of what patients need from their oncologists and encourage open discussion on controversial issues such as Hormone Replacement Therapy, complementary medicine, screening, and new treatments.

Supported by various European cancer groups, a Second European Patient Seminar (Saturday, 21 June 2003) will attempt to move beyond patient-physician communication to patient-physician partnership. Reflecting the true spirit of partnership,

  • Patients have collaborated with oncologists in planning an extremely interesting program,
  • Lectures will be given by both patients and physicians,
  • Patients and oncologists will meet for an interactive joint session, where both sides will express and explain their positions on current issues in oncology.

Come join us and be the first to know what patients want from their ideal cancer doctor, what doctors expect from patients, what can be done to improve communication, reinforce partnership, and ultimately improve healthcare services for cancer patients.

Planned Press Activities:

ESMO President and ESEC Working Party Meet the Press
Saturday, 21 June, 09.00-10.15

Press Conference:

  • Patient-physician partnership
  • Patient Advocacy - Moving the political agenda forward

Saturday, 21 June, 12.30-13.30

Free Media Registration is grant
'"/>

Contact: Gracemarie Bricalli
gracemarie@esmo.org
0041-919-731-911
European Society for Medical Oncology
19-May-2003


Page: 1 2

Related biology news :

1. Summer in the South: Kudzu and oriental bittersweet
2. Summer of the Shark in 2001 more hype than fact, new numbers show
3. Summer 2000 techNotes
4. Seabed Silt In Indian Ocean Consists Of Remains Of Summer Plankton
5. Summer Science: Where Have All The Honeybees Gone? UD Bee Guy Asks Why--From America To The Amazon
6. Gene Transfer Process Generates Seedless Summer Days
7. Summer Science: Firefly Babies Advertise Their Bitter Taste, UD Researchers Say
8. Educational program increases some safety behaviors for older drivers
9. New Genetics Of Cancer Educational Website Is On-line
10. APS Inflammatory Bowel Diseases Translational Research Conference, Sept. 8-11

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2020)... ... ... Modality Solutions, a biopharmaceutical cold chain validation engineering firm, is pleased ... the most prestigious ranking of the nation’s fastest-growing private companies. Modality Solutions made the ... revenue growth of 71 percent. , The Inc. 5000 list represents a unique ...
(Date:8/21/2020)... ... 2020 , ... NDA Partners Chairman Carl Peck, MD ... expertise in clinical trial planning and feasibility, regulatory inspection readiness, and clinical investigator ... career, Mr. Movahhed has helped design and manage oncology, neurology, cardiovascular, and anti-infective ...
(Date:8/5/2020)... ... August 05, 2020 , ... Regenative Labs has received approval from the Centers ... making them the first Wharton’s jelly allografts to be assigned a Q code and ... are the first Wharton’s jelly allograft product to be recognized as a 361 HCT/P ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... July 16, 2020 , ... “We are thrilled to deliver this ... the only technology of its kind on the market and we were pleased that ... protective capacity of traditional cultured ingredients, creating a natural way to extend the shelf ...
(Date:7/10/2020)... (PRWEB) , ... July 08, 2020 , ... ... services and products, announces a significant expansion of laboratory operations through its ... for agencies implementing testing programs. , Bode-CARES provides a turnkey ...
(Date:7/10/2020)... ... 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology company ... Nissenson, M.D., F.A.C.P., as its Chief Medical Officer. Dr. Nissenson will join ... Dr. Nissenson serves as an Emeritus Professor of Medicine at the David ...
(Date:7/1/2020)... ... 29, 2020 , ... MedShift , a leading medical ... many obstacles created as a result of COVID-19. As a provider at the ... practices and medical manufacturers by expanding access to device offerings, technology services, and ...
Breaking Biology Technology:
Cached News: